Microbiomes – Products
Product News
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
Product News
PacBio Announces Kinnex RNA Kits
Building on the MAS-seq concatenation method, these three new kits can significantly increase throughput in RNA application.
Product News
Owlstone Medical Launches OMED Health To Help Patients Manage Their Digestive Health
Owlstone Medical has announced the launch of OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care devices and support resources for a range of conditions.
App Note / Case Study
Creating a More Human-Relevant Model of the Small Intestine with Organ-Chip Technology
Current in vitro models of the small intestine offer limited predictivity due to their reliance on immortalized cell lines and static culture. To better predict human response to drug candidates, researchers need a model than can more closely recreate the intestinal microenvironment.
Product News
CN Bio Licenses Human Gut Microbiome Modelling Tool from MIT and Northeastern University
CN Bio has announced it has secured the licensing rights to a novel tool for modelling the gut microbiome, GuMI, from Massachusetts Institute of Technology (MIT) and Northeastern University.
Product News
Celemics Partners With Strand Life Science To Provide Compliant Bioinformatics Solution
Celemics co-founder and CEO Dr. Hyoki Kim announced a partnership with Strand Life Sciences to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality,
Product News
Beckman Coulter Life Sciences Launches Next-Generation BioLector XT Microbioreactor
Microbioreactor technology is accelerating and increasing automation capabilities with the launch of the new BioLector XT Microbioreactor.
Whitepaper
Developing a New Modality Using Targeted Therapeutic Discovery
Download this case study to learn more about how Thermo Scientific Core LIMS™ and Core ELN™ software solutions are supporting efforts to develop the human microbiome into a new modality for drug development.
App Note / Case Study
Rapid Workflow for Detection of Select Bacteria in Samples
The human digestive tract is home to > 1,000 different species of microorganisms. Purification of microbial DNA from a sample is a key step in understanding the microbiome composition and its influences on human health. Download this app note to discover a detection workflow that can be performed in as little as 2 hours.
Product News
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100
BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.
Advertisement
